المؤلفون: Hollestein, L. M., Lo, S. N., Leonardi‐Bee, J., Rosset, S., Shomron, N., Couturier, D.-L., Gran, S.

مصطلحات موضوعية: Dermatology

العلاقة: https://nottingham-repository.worktribe.com/output/5719944Test; British Journal of Dermatology; Volume 185; Issue 6; Pagination 1081-1083; https://nottingham-repository.worktribe.com/file/5719944/1/Hollestein%20Et%20Al%202021Test

الإتاحة: https://doi.org/10.1111/bjd.20600Test
https://nottingham-repository.worktribe.com/file/5719944/1/Hollestein%20Et%20Al%202021Test
https://nottingham-repository.worktribe.com/output/5719944Test

المؤلفون: Owen, C. N., Bai, X., Quah, T., Lo, S. N., Allayous, C., Callaghan, S., Martínez-Vila, C., Wallace, R., Bhave, P., Reijers, I. L.M., Thompson, N., Vanella, V., Gerard, C. L., Aspeslagh, S., Labianca, A., Khattak, A., Mandala, M., Xu, W., Neyns, B., Michielin, O., Blank, C. U., Welsh, S. J., Haydon, A., Sandhu, S., Mangana, J., McQuade, J. L., Ascierto, P. A., Zimmer, L., Johnson, D. B., Arance, A., Lorigan, P., Lebbé, C., Carlino, M. S., Sullivan, R. J., Long, G. V., Menzies, A. M.

المصدر: Owen , C N , Bai , X , Quah , T , Lo , S N , Allayous , C , Callaghan , S , Martínez-Vila , C , Wallace , R , Bhave , P , Reijers , I L M , Thompson , N , Vanella , V , Gerard , C L , Aspeslagh , S , Labianca , A , Khattak , A , Mandala , M , Xu , W , Neyns , B , Michielin , O , Blank , C U , Welsh , S J , Haydon , A , ....

مصطلحات موضوعية: anti-PD-1, delayed, Immunotherapy, irAE, melanoma, toxicity, ResearchInstitutes_Networks_Beacons/mcrc, Manchester Cancer Research Centre

الإتاحة: https://doi.org/10.1016/j.annonc.2021.03.204Test
https://research.manchester.ac.uk/en/publications/623e0152-4a5d-40d0-9790-45b1541f958aTest
http://www.scopus.com/inward/record.url?scp=85106308600&partnerID=8YFLogxKTest

المؤلفون: Rawson, R. V., Adhikari, C., Bierman, C., Lo, S. N., Shklovskaya, E., Rozeman, E. A., Menzies, A. M., van Akkooi, A. C. J., Shannon, K. F., Gonzalez, M., Guminski, A. D., Tetzlaff, M. T., Stretch, J. R., Eriksson, H., van Thienen, J. V., Wouters, M. W., Haanen, J. B. A. G., Klop, W. M. C., Zuur, C. L., van Houdt, W. J., Nieweg, O. E., Ch'ng, S., Rizos, H., Saw, R. P. M., Spillane, A. J., Wilmott, J. S., Blank, C. U., Long, G. V., van de Wiel, B. A., Scolyer, R. A.

المصدر: Rawson , R V , Adhikari , C , Bierman , C , Lo , S N , Shklovskaya , E , Rozeman , E A , Menzies , A M , van Akkooi , A C J , Shannon , K F , Gonzalez , M , Guminski , A D , Tetzlaff , M T , Stretch , J R , Eriksson , H , van Thienen , J V , Wouters , M W , Haanen , J B A G , Klop , W M C , Zuur , C L , van Houdt , ....

مصطلحات موضوعية: immunotherapy, metastatic melanoma, neoadjuvant, pathological response

الإتاحة: https://doi.org/10.1016/j.annonc.2021.03.006Test
https://researchers.mq.edu.au/en/publications/f0818b31-a359-4ed3-ab13-670ab66b6837Test
http://www.scopus.com/inward/record.url?scp=85105246335&partnerID=8YFLogxKTest
http://purl.org/au-research/grants/nhmrc/1141295Test
http://purl.org/au-research/grants/nhmrc/1119059Test
http://purl.org/au-research/grants/nhmrc/1104503Test

المؤلفون: Lo, S. N. G.

مرشدي الرسالة: Norton, Brian

الإتاحة: http://hdl.handle.net/1826/3935Test

المؤلفون: Bai X., Shaheen A., Grieco C., d'Arienzo P. D., Mina F., Czapla J. A., Lawless A. R., Bongiovanni E., Santaniello U., Zappi H., Dulak D., Williamson A., Lee R., Gupta A., Li C., Si L., Ubaldi M., Yamazaki N., Ogata D., Johnson R., Park B. C., Jung S., Madonna G., Hochherz J., Umeda Y., Nakamura Y., Gebhardt C., Festino L., Capone M., Ascierto P. A., Johnson D. B., Lo S. N., Long G. V., Menzies A. M., Namikawa K., Mandala' M., Guo J., Lorigan P., Najjar Y. G., Haydon A., Quaglino P., Boland G. M., Sullivan R. J., Furness A. J. S., Plummer R., Flaherty K. T.

المساهمون: Bai, X., Shaheen, A., Grieco, C., D'Arienzo, P. D., Mina, F., Czapla, J. A., Lawless, A. R., Bongiovanni, E., Santaniello, U., Zappi, H., Dulak, D., Williamson, A., Lee, R., Gupta, A., Li, C., Si, L., Ubaldi, M., Yamazaki, N., Ogata, D., Johnson, R., Park, B. C., Jung, S., Madonna, G., Hochherz, J., Umeda, Y., Nakamura, Y., Gebhardt, C., Festino, L., Capone, M., Ascierto, P. A., Johnson, D. B., Lo, S. N., Long, G. V., Menzies, A. M., Namikawa, K., Mandala', M., Guo, J., Lorigan, P., Najjar, Y. G., Haydon, A., Quaglino, P., Boland, G. M., Sullivan, R. J., Furness, A. J. S., Plummer, R., Flaherty, K. T.

مصطلحات موضوعية: Adjuvant therapy, BRAF V600 mutation, Dabrafenib/trametinib, Melanoma, PD-1

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37965433; info:eu-repo/semantics/altIdentifier/wos/WOS:001103768700001; volume:65; firstpage:102290; journal:ECLINICALMEDICINE; https://hdl.handle.net/11391/1566826Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85175344262

الإتاحة: https://doi.org/10.1016/j.eclinm.2023.102290Test
https://hdl.handle.net/11391/1566826Test

المؤلفون: Dimitriou F., Namikawa K., Reijers I. L. M., Buchbinder E. I., Soon J. A., Zaremba A., Teterycz P., Mooradian M. J., Armstrong E., Nakamura Y., Vitale M. G., Tran L. E., Bai X., Allayous C., Provent-Roy S., Indini A., Bhave P., Farid M., Kahler K. C., Mehmi I., Atkinson V., Klein O., Stonesifer C. J., Zaman F., Haydon A., Carvajal R. D., Hamid O., Dummer R., Hauschild A., Carlino M. S., Mandala' M., Robert C., Lebbe C., Guo J., Johnson D. B., Ascierto P. A., Shoushtari A. N., Sullivan R. J., Cybulska-Stopa B., Rutkowski P., Zimmer L., Sandhu S., Blank C. U., Lo S. N., Menzies A. M., Long G. V.

المساهمون: Dimitriou, F., Namikawa, K., Reijers, I. L. M., Buchbinder, E. I., Soon, J. A., Zaremba, A., Teterycz, P., Mooradian, M. J., Armstrong, E., Nakamura, Y., Vitale, M. G., Tran, L. E., Bai, X., Allayous, C., Provent-Roy, S., Indini, A., Bhave, P., Farid, M., Kahler, K. C., Mehmi, I., Atkinson, V., Klein, O., Stonesifer, C. J., Zaman, F., Haydon, A., Carvajal, R. D., Hamid, O., Dummer, R., Hauschild, A., Carlino, M. S., Mandala', M., Robert, C., Lebbe, C., Guo, J., Johnson, D. B., Ascierto, P. A., Shoushtari, A. N., Sullivan, R. J., Cybulska-Stopa, B., Rutkowski, P., Zimmer, L., Sandhu, S., Blank, C. U., Lo, S. N., Menzies, A. M., Long, G. V.

مصطلحات موضوعية: anti-PD-1, ethnicity/race, immunotherapy, ipilimumab, mucosal melanoma

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35716907; info:eu-repo/semantics/altIdentifier/wos/WOS:000859953000004; volume:33; issue:9; firstpage:968; lastpage:980; numberofpages:13; journal:ANNALS OF ONCOLOGY; https://hdl.handle.net/11391/1566856Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85134324353

الإتاحة: https://doi.org/10.1016/j.annonc.2022.06.004Test
https://hdl.handle.net/11391/1566856Test

المؤلفون: Dimitriou, Florentia, Lo, S N, Tan, A C, Emmett, L, Kapoor, R, Carlino, M S, Long, G V, Menzies, A M

الإتاحة: https://doi.org/10.5167/uzh-211479Test
https://www.zora.uzh.ch/id/eprint/211479Test

المؤلفون: Dimitriou, Florentia, Namikawa, K, Reijers, I L M, Dummer, Reinhard, Lo, S N, Menzies, A M, Long, G V

المصدر: Dimitriou, Florentia; Namikawa, K; Reijers, I L M; et al; Dummer, Reinhard; Lo, S N; Menzies, A M; Long, G V (2022). Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study. Annals of Oncology, 33(9):968-980.

مصطلحات موضوعية: Dermatology Clinic, 610 Medicine & health, Oncology, Hematology

وصف الملف: application/pdf

العلاقة: https://www.zora.uzh.ch/id/eprint/224722/1/953_Dimitriou_F._et_al._Single_agent_anti_PD_1_or_combined_with_ipilimumab_in_patients_with_mucosal_melanoma_ESMO_2022.pdfTest; info:pmid/35716907; urn:issn:0923-7534

الإتاحة: https://doi.org/10.5167/uzh-22472210.1016/j.annonc.2022.06.004Test
https://www.zora.uzh.ch/id/eprint/224722Test/
https://www.zora.uzh.ch/id/eprint/224722/1/953_Dimitriou_F._et_al._Single_agent_anti_PD_1_or_combined_with_ipilimumab_in_patients_with_mucosal_melanoma_ESMO_2022.pdfTest

المؤلفون: Bhave, P., Ahmed, T., Lo, S. N., Shoushtari, A., Zaremba, A., Versluis, J. M., Mangana, J., Weichenthal, M., Si, L., Lesimple, T., Robert, C., Trojanello, C., Wicky, A., Heywood, Richard, Tran, L., Batty, K., Dimitriou, F., Stansfeld, A., Allayous, C., Schwarze, J. K., Mooradian, M. J., Klein, O., Mehmi, I., Roberts-Thomson, R., Maurichi, A., Yeoh, H. L., Khattak, A., Zimmer, L., Blank, C. U., Ramelyte, E., Kähler, K. C., Roy, S., Ascierto, P. A., Michielin, O., Lorigan, Paul C, Johnson, D. B., Plummer, R., Lebbe, C., Neyns, B., Sullivan, R., Hamid, O., Santinami, M., McArthur, G. A., Haydon, A. M., Long, G. V., Menzies, A. M., Carlino, M. S.

المساهمون: Sir Peter MacCallum Cancer Centre Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

العلاقة: https://dx.doi.org/10.1136/jitc-2022-004668Test; Bhave P, Ahmed T, Lo SN, Shoushtari A, Zaremba A, Versluis JM, et al. Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma. Journal for immunotherapy of cancer. 2022 Jul;10(7). PubMed PMID: 35793872. Pubmed Central PMCID: PMC9260790. Epub 2022/07/07. eng.; http://hdl.handle.net/10541/625417Test; Journal for Immunotherapy of Cancer

الإتاحة: https://doi.org/10.1136/jitc-2022-004668Test
http://hdl.handle.net/10541/625417Test

المؤلفون: Pires da Silva, I., Ahmed, T., McQuade, J. L., Nebhan, C. A., Park, J. J., Versluis, J. M., Serra-Bellver, P., Khan, Y., Slattery, T., Oberoi, H. K., Ugurel, S., Haydu, L. E., Herbst, R., Utikal, J., Pföhler, C., Terheyden, P., Weichenthal, M., Gutzmer, R., Mohr, P., Rai, R., Smith, J. L., Scolyer, R. A., Arance, A. M., Pickering, L., Larkin, J., Lorigan, P., Blank, C. U., Schadendorf, D., Davies, M. A., Carlino, M. S., Johnson, D. B., Long, G. V., Lo, S. N., Menzies, A. M.

المساهمون: Melanoma Institute Australia, The University of Sydney, Sydney, Australia. Charles Perkins Centre, The University of Sydney, Sydney, Australia. Westmead and Blacktown Hospitals, Sydney, Australia. The University of Texas MD Anderson Cancer Center, Houston, TX. Vanderbilt University Medical Center, Nashville, TN. Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia. Netherlands Cancer Institute, Amsterdam, the Netherlands. The Christie NHS Foundation Trust, Manchester, United Kingdom. The Royal Marsden NHS Foundation Trust, London, United Kingdom. Hospital Clinic, Barcelona & IDIBAPS, Barcelona, Spain. University Hospital Essen, University of Duisburg-Essen, German Cancer Consortium, Partner Site Essen, Essen, Germany. Helios Klinikum Erfurt, Erfurt, Germany. Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. Saarland University Medical Center, Homburg/Saar, Germany. Department of Dermatology, University of Lübeck, Lübeck, Germany. University Skin Cancer Center Kiel, University Hospital of Schleswig-Holstein, Kiel, Germany. Skin Cancer Center, Department of Dermatology, Mühlenkreiskliniken, Ruhr University Bochum Campus Minden, Minden, Germany. Elbe-Klinikum Buxtehude, Buxtehude, Germany. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, Australia. Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom. Royal North Shore and Mater Hospitals, Sydney, Australia.

العلاقة: https://dx.doi.org/10.1200/jco.21.01701Test; Pires da Silva I, Ahmed T, McQuade JL, Nebhan CA, Park JJ, Versluis JM, et al. Clinical Models to Define Response and Survival With Anti–PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma [Internet]. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022.; http://hdl.handle.net/10541/625099Test; Journal of Clinical Oncologoy

الإتاحة: https://doi.org/10.1200/jco.21.01701Test
http://hdl.handle.net/10541/625099Test